Literature DB >> 16806186

Oxidative stress in the brain at early preclinical stages of mouse scrapie.

Seong-Wook Yun1, Manfred Gerlach, Peter Riederer, Michael A Klein.   

Abstract

Oxidative stress has been shown to be involved in the pathogenesis of neurodegenerative diseases including prion diseases. Although a growing body of evidence suggests direct involvement of oxidative stress in the pathogenesis of prion diseases, it is still not clear whether oxidative stress is a causative early event in these conditions or a secondary phenomenon commonly found in the progression of neurodegenerative diseases. Using a mouse scrapie model, we assessed oxidative stress in the brain at various stages of the disease progression and observed significantly increased concentration of lipid peroxidation markers, malondialdehyde and 4-hydroxyalkenals, and mRNA level of an oxidative stress response enzyme, heme oxygenase-1, at early preclinical stages of scrapie. The changes preceded dramatic synaptic loss demonstrated by immunohistochemical staining of a synaptic protein, synaptophysin. These findings imply that the brain undergoes oxidative stress even from an early stage of prion invasion into the brain. Given the well-known deleterious effects of reactive-oxygen-species-mediated damage in the brain, it is considered that the oxidative stress at the preclinical stage of prion diseases may predispose the brain to neurodegenerative mechanisms that characterize the diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16806186     DOI: 10.1016/j.expneurol.2006.03.025

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  19 in total

Review 1.  Redox control of prion and disease pathogenesis.

Authors:  Neena Singh; Ajay Singh; Dola Das; Maradumane L Mohan
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

2.  Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt-Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress.

Authors:  Waqas Tahir; Saima Zafar; Franc Llorens; Amandeep Singh Arora; Katrin Thüne; Matthias Schmitz; Nadine Gotzmann; Niels Kruse; Brit Mollenhauer; Juan Maria Torres; Olivier Andréoletti; Isidre Ferrer; Inga Zerr
Journal:  Mol Neurobiol       Date:  2016-12-14       Impact factor: 5.590

3.  Mutant prion protein expression is associated with an alteration of the Rab GDP dissociation inhibitor alpha (GDI)/Rab11 pathway.

Authors:  Tania Massignan; Emiliano Biasini; Eliana Lauranzano; Pietro Veglianese; Mauro Pignataro; Luana Fioriti; David A Harris; Mario Salmona; Roberto Chiesa; Valentina Bonetto
Journal:  Mol Cell Proteomics       Date:  2009-12-07       Impact factor: 5.911

4.  Infectious prion protein alters manganese transport and neurotoxicity in a cell culture model of prion disease.

Authors:  Dustin P Martin; Vellareddy Anantharam; Huajun Jin; Travis Witte; Robert Houk; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Neurotoxicology       Date:  2011-08-19       Impact factor: 4.294

Review 5.  Therapeutic strategies for identifying small molecules against prion diseases.

Authors:  Elisa Uliassi; Lea Nikolic; Maria Laura Bolognesi; Giuseppe Legname
Journal:  Cell Tissue Res       Date:  2022-01-06       Impact factor: 5.249

6.  Role of proteolytic activation of protein kinase Cδ in the pathogenesis of prion disease.

Authors:  Dilshan S Harischandra; Naveen Kondru; Dustin P Martin; Arthi Kanthasamy; Huajun Jin; Vellareddy Anantharam; Anumantha G Kanthasamy
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

7.  Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cells.

Authors:  Sophie Mouillet-Richard; Noriyuki Nishida; Elodie Pradines; Hubert Laude; Benoît Schneider; Cécile Féraudet; Jacques Grassi; Jean-Marie Launay; Sylvain Lehmann; Odile Kellermann
Journal:  J Biol Chem       Date:  2008-07-09       Impact factor: 5.157

8.  The tyrosine kinase inhibitor imatinib mesylate delays prion neuroinvasion by inhibiting prion propagation in the periphery.

Authors:  Seong-Wook Yun; Alexa Ertmer; Eckhard Flechsig; Sabine Gilch; Peter Riederer; Manfred Gerlach; Hermann M Schätzl; Michael A Klein
Journal:  J Neurovirol       Date:  2007-08       Impact factor: 2.643

Review 9.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

10.  Exposure of RML scrapie agent to a sodium percarbonate-based product and sodium dodecyl sulfate renders PrPSc protease sensitive but does not eliminate infectivity.

Authors:  Jodi D Smith; Eric M Nicholson; Gregory H Foster; Justin J Greenlee
Journal:  BMC Vet Res       Date:  2013-01-11       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.